Robert T. Keenan, MD, MPH
Department / Division
Medicine /
Medicine-Rheumatology and Immunology
Address
DUMC 3544
Durham, NC 27710
Appointment Telephone
919-613-2243
Office Telephone
919-684-4499
Fax Telephone
919-684-8358
- MD, Saint George's University School of Medicine (West Indies), 2004
- Internal Medicine, Saint Louis University Hospital (Missouri), 2007
- Rheumatology, New York University Hospital for Joint Diseases, 2009
- MPH, University of North Carolina–Chapel Hill, 2000
Clinical Interests
Gout and other crystal arthropathies, inflammatory eye diseases, general rheumatology, clinical outcomes research
Research Interests
Dr. Keenan's research interests include crystal arthropathies, with a focus on gout, and associated co-morbidities; seronegative arthritis and spondylarthropathies; and inflammatory eye disease.
This faculty member (or a member of their immediate family) has a working relationship (i.e. consulting, research, and/or educational services) with the companies listed below. These relations have been reported to the health system leadership and, when appropriate, management plans are in place to address potential conflicts.
- Abbott Laboratories
- Amgen, Inc.
- Fortis Spectrum
- Genentech, Inc (Roche Holding)
- Health Education Alliance
- Med Ed Rules
- Novartis
- Novartis
- Savient Pharmaceuticals, Inc
Representative Publications
Keenan, RT; O'Brien, WR; Lee, KH; Crittenden, DB; Fisher, MC; Goldfarb, DS; Krasnokutsky, S; Oh, C; Pillinger, MH. Prevalence of contraindications and prescription of pharmacologic therapies for gout. American Journal of Medicine. 2011;124:155-163.
(2011)
Abstract
Ning, TC; Keenan, RT. Unusual clinical presentations of gout. Current Opinion in Rheumatology. 2010;22:181-187.
(2010)
Abstract
Pillinger, MH; Goldfarb, DS; Keenan, RT. Gout and its comorbidities. Bulletin of the NYU Hospital for Joint Diseases. 2010;68:199-203.
(2010)
Abstract
Samuels, J; Keenan, RT; Yu, R; Pillinger, MH; Bescke, T. Erosive spinal tophus in a patient with gout and back pain. Bulletin of the NYU Hospital for Joint Diseases. 2010;68:147-148.
(2010)
Abstract
Shah, A; Keenan, RT. Gout, hyperuricemia, and the risk of cardiovascular disease: cause and effect?. Current Rheumatology Reports. 2010;12:118-124.
(2010)
Abstract
Keenan, RT; Hamalian, GM; Pillinger, MH. RS3PE presenting in a unilateral pattern: case report and review of the literature. Seminars in Arthritis and Rheumatism. 2009;38:428-433.
(2009)
Abstract
Keenan, RT; Pillinger, MH. Febuxostat: a new agent for lowering serum urate. Drugs of Today. 2009;45:247-260.
(2009)
Abstract
Keenan, RT; Pillinger, MH. Hyperuricemia, gout, and cardiovascular disease--an important "muddle". Bulletin of the NYU Hospital for Joint Diseases. 2009;67:285-290.
(2009)
Abstract
Keenan, RT; Swearingen, CJ; Yazici, Y. Erythrocyte sedimentation rate and C-reactive protein levels are poorly correlated with clinical measures of disease activity in rheumatoid arthritis, systemic lupus erythematosus and osteoarthritis patients. Clinical and Experimental Rheumatology. 2008;26:814-819.
(2008)
Abstract
Pillinger, MH; Keenan, RT. Update on the management of hyperuricemia and gout. Bulletin of the NYU Hospital for Joint Diseases. 2008;66:231-239.
(2008)
Abstract
